Vitrafy Life Sciences inks cryopreservation deal for Charter Medical hub
Vitrafy Life Sciences (ASX: VFY) secured an agreement with North Carolina-based Charter Medical to deploy its cryopreservation ecosystem into Charter’s Innovation Hub for single-use biopharma cold chain logistics and cell therapy.
Vitrafy Life Sciences ASX:VFY has made its entry into the US cell and gene therapy market by securing an agreement with North Carolina-based Charter Medical to deploy its cryopreservation ecosystem into Charter’s Innovation Hub focused on single-use biopharma cold chain logistics and cell therapy d…